PDCD1 and neoplasm: Approaches such as immune checkpoint inhibitors (PD-1/PD-L1 inhibitors), CAR-T cell therapy, and other methods can stimulate the body’s immune system, thereby influencing the polarization state of tumor-associated macrophages (124, 125) (Figure 6).